The Pharmacodynamics of Cannabinoid-Caffeine Combinations

A Double-Blind, Randomized, Placebo-Controlled, Within-Subject Crossover Study of the Effects of Combinations of Cannabinoids and Caffeine

NCT05478863•Johns Hopkins University

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Behavioral Pharmacology of Cannabinoids

Interventions

Oral Placebo

Oral THC

+2 more

Locations

United States

Locations (1)

Johns Hopkins University School of Medicine BPRU

Baltimore, Maryland, United States

Key Dates

Start Date

January 20, 2023

Primary Completion Date

October 2, 2024

Completion Date

October 2, 2024

Last Updated

October 8, 2024

Sponsors

Lead Sponsor

Johns Hopkins University

Collaborators

Canopy Growth Corporation

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 8, 2024Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions